274 related articles for article (PubMed ID: 28425216)
1. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.
Qian CJ; Coulombe J; Suissa S; Ernst P
Br J Clin Pharmacol; 2017 Sep; 83(9):2077-2086. PubMed ID: 28425216
[TBL] [Abstract][Full Text] [Related]
2. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S; Rottier BL; Scholten RJ; Boluyt N
Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
[TBL] [Abstract][Full Text] [Related]
3. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
O'Byrne PM; Pedersen S; Carlsson LG; Radner F; Thorén A; Peterson S; Ernst P; Suissa S
Am J Respir Crit Care Med; 2011 Mar; 183(5):589-95. PubMed ID: 20889908
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
Choi JH; Jeong KB; Park YH; Yu I; Lee SJ; Lee MK; Kim SH; Lee WY; Yong SJ; Lee JH
Int J Chron Obstruct Pulmon Dis; 2021; 16():3229-3237. PubMed ID: 34858023
[TBL] [Abstract][Full Text] [Related]
5. The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids.
Martin MJ; Zain NMM; Hearson G; Rivett DW; Koller G; Wooldridge DJ; Rose G; Gharbia SE; Forbes B; Bruce KD; Harrison TW
PLoS One; 2020; 15(12):e0244681. PubMed ID: 33378384
[TBL] [Abstract][Full Text] [Related]
6. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson LG; Sin DD
Respir Med; 2012 Nov; 106(11):1487-93. PubMed ID: 22902134
[TBL] [Abstract][Full Text] [Related]
7. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
Chen H; Feng Y; Wang K; Yang J; Du Y
BMC Pulm Med; 2020 Oct; 20(1):282. PubMed ID: 33115481
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
Yang M; Du Y; Chen H; Jiang D; Xu Z
Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
[TBL] [Abstract][Full Text] [Related]
9. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
11. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
Lodise TP; Li J; Gandhi HN; O'Brien G; Sethi S
Int J Chron Obstruct Pulmon Dis; 2020; 15():2889-2900. PubMed ID: 33204085
[TBL] [Abstract][Full Text] [Related]
12. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
[TBL] [Abstract][Full Text] [Related]
13. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
[TBL] [Abstract][Full Text] [Related]
14. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
Janson C; Stratelis G; Miller-Larsson A; Harrison TW; Larsson K
Int J Chron Obstruct Pulmon Dis; 2017; 12():3055-3064. PubMed ID: 29089754
[TBL] [Abstract][Full Text] [Related]
15. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
16. Risk of pneumonia in asthmatic children using inhaled corticosteroids: a nested case-control study in a birth cohort.
Shrestha P; Wi CI; Liu H; King KS; Ryu E; Kwon JH; Sohn S; Park M; Juhn Y
BMJ Open; 2022 Mar; 12(3):e051926. PubMed ID: 35273042
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia.
Suissa S; Coulombe J; Ernst P
Chest; 2015 Nov; 148(5):1177-1183. PubMed ID: 26110239
[TBL] [Abstract][Full Text] [Related]
18. Inhaled Corticosteroids Use and Risk of Invasive Pneumococcal Disease in a Population-based Study.
Torén K; Blanc PD; Qvarfordt I; Aspevall O; Schiöler L
Ann Am Thorac Soc; 2020 Dec; 17(12):1570-1575. PubMed ID: 32649216
[No Abstract] [Full Text] [Related]
19. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
20. Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.
Hirst C; Calingaert B; Stanford R; Castellsague J
J Asthma; 2010 May; 47(4):439-46. PubMed ID: 20528600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
